Stuart W. Peltz

2019

In 2019, Stuart W. Peltz earned a total compensation of $7.8M as Chief Executive Officer at PTC Therapeutics, a 93% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$723,950
Option Awards$6,316,691
Salary$702,000
Other$16,800
Total$7,759,441

Peltz received $6.3M in option awards, accounting for 81% of the total pay in 2019.

Peltz also received $724K in non-equity incentive plan, $702K in salary and $16.8K in other compensation.

Rankings

In 2019, Stuart W. Peltz's compensation ranked 1,143rd out of 13,971 executives tracked by ExecPay. In other words, Peltz earned more than 91.8% of executives.

ClassificationRankingPercentile
All
1,143
out of 13,971
92nd
Division
Manufacturing
396
out of 5,701
93rd
Major group
Chemicals And Allied Products
119
out of 2,200
95th
Industry group
Drugs
95
out of 1,886
95th
Industry
Pharmaceutical Preparations
72
out of 1,398
95th
Source: SEC filing on April 29, 2021.

Peltz's colleagues

We found four more compensation records of executives who worked with Stuart W. Peltz at PTC Therapeutics in 2019.

2019

Marcio Souza

PTC Therapeutics

Chief Operating Officer

2019

Neil Almstead

PTC Therapeutics

Chief Technical Operations Officer

2019

Mark Boulding

PTC Therapeutics

Chief Legal Officer

2019

Emily Hill

PTC Therapeutics

Chief Financial Officer

News

In-depth

You may also like